|
Ingelvac CircoFLEX
|
-
|
EU/2/07/079/002
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI09AA07
|
pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated recombinant Porcine Circovirus type 2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
| Date of authorisation/renewal: |
13-Feb-2008
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/079/002 |
|
1 |
ABPE pudele, 50 deva |
-
|
|
|
Cardalis
|
-
|
EU/2/12/142/005
|
Ceva Sante Animale, Francija
|
QC09BA07
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Spironolactone,Benazepril hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
28-Aug-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/12/142/005 |
10 mg/80 mg |
30 |
Pudele, 1 tablete |
-
|
|
|
BLUEVAC-3
|
-
|
EU/2/24/331/001
|
CZ Vaccines S.A.U., Spānija
|
QI04AA02
|
cattle; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Bluetongue virus, serotype 3 (BTV-3), strain BTV-3/NET2023, inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
20-Feb-2025
|
| Marketing authorisation valid until: |
19-Feb-2026
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/331/001 |
|
1 |
ABPE pudele, 52 ml |
-
|
|
|
Numelvi
|
31.6 mg
|
EU/2/25/351/008
|
Intervet International B.V., Nīderlande
|
QD11AH93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Atinvicitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/351/008 |
31,6 mg/tabl. |
3 |
Blisteris, 30 tablete |
-
|
|
|
Profender spot-on solution for small cats
|
-
|
EU/2/05/054/003
|
Vetoquinol S.A., Francija
|
QP52AA51
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Praziquantel,Emodepside
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
27-Jul-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/05/054/003 |
|
12 |
Pipete, 1 deva |
-
|
|
|
RESPIVAC TRT
|
-
|
EU/2/24/314/007
|
Laboratorios Hipra S.A., Spānija
|
QI01AD01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension/use in drinking water
|
| International name (active substance): |
Turkey rhinotracheitis virus, strain 1062, Live
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
30-May-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/314/007 |
|
10 |
Stikla flakons, 5000 devas/flakonā |
-
|
|
|
Numelvi
|
4.8 mg
|
EU/2/25/351/009
|
Intervet International B.V., Nīderlande
|
QD11AH93
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Atinvicitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Jul-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/351/009 |
4,8 mg/tabl. |
1 |
ABPE pudele, 30 tablete |
-
|
|
|
Stronghold
|
60 mg
|
EU/2/99/014/014
|
Zoetis Belgium S.A., Beļģija
|
QP54AA05
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Service Company bvba, Beļģija
|
| Date of authorisation/renewal: |
07-Apr-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/014/014 |
60 mg/ml |
6 |
Polipropilēna pipete, 1 deva |
-
|
|
|
Rheumocam
|
5.0 mg/ml
|
EU/2/07/078/016
|
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
QM01AC06
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
|
| Date of authorisation/renewal: |
18-Dec-2012
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/07/078/016 |
5 mg/ml |
1 |
Stikla flakons, 20 ml |
-
|
|
|
Epizootic haemorrhagic disease vaccine (recombinant protein) Laboratorios Syva S.A.
|
-
|
EU/2/25/360/003
|
LABORATORIOS SYVA S.A., Spānija
|
QI02AA
|
cattle
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Epizootic haemorrhagic disease virus, serotype 8, VP2 protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios SYVA S.A., Spānija
|
| Date of authorisation/renewal: |
29-Jan-2026
|
| Marketing authorisation valid until: |
28-Jan-2027
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/360/003 |
|
1 |
ABPE flakons (kartona kastē), 100 ml |
-
|
|
|
Nobivac LoVo L4
|
-
|
EU/2/23/304/001
|
Intervet International B.V., Nīderlande
|
QI07AB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated, Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
20-Nov-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/304/001 |
|
10 |
Stikla flakons, 1 ml/deva |
-
|
|
|
Purevax RC
|
-
|
EU/2/04/051/002
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QI06AH08
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Attenuated feline rhinotracheitis herpesvirus,Inactivated feline Calicivirosis antigens
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial Laboratory of Lyon Porte des Alpes, Francija
|
| Date of authorisation/renewal: |
23-Feb-2005
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/051/002 |
1 ml/deva |
50 |
Pudele, 1 deva |
-
|
|
|
Rhiniseng
|
-
|
EU/2/10/109/004
|
Laboratorios Hipra S.A., Spānija
|
QI09AB04
|
sows; gilt
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Pasteurella multocida Serotype D,Inactivated Bordetella bronchiseptica
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Hipra S.A., Spānija
|
| Date of authorisation/renewal: |
15-Sep-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/10/109/004 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
Advocate Spot-on maziem kaķiem un seskiem
|
-
|
EU/2/03/039/033
|
Bayer Animal Health , Vācija
|
QP54AB52
|
ferrets; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
16-Jul-2007
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/033 |
|
9 |
Pipete, 0,4 ml |
-
|
|
|
APOQUEL
|
3.6 mg
|
EU/2/13/154/029
|
Zoetis Belgium S.A., Beļģija
|
QD11AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Chewable tablet
|
| International name (active substance): |
Oclacitinib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
13-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/154/029 |
3,6 mg |
10 |
Blisteris, 10 tablete |
-
|
|
|
Lotilaner/Milbemycin Elanco 900 mg/33,75 mg
|
-
|
EU/2/26/361/019
|
Elanco GmbH, Vācija
|
QP54AB51
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Lotilaner, Milbemycin oxime
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Elanco France S.A.S, Francija
|
| Date of authorisation/renewal: |
25-Feb-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/26/361/019 |
|
6 |
Al/Al blisteris, 1 tablete |
-
|
|
|
Tulinovet
|
100 mg/ml
|
EU/2/20/257/003
|
V.M.D. n.v., Beļģija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
V.M.D. n.v., Beļģija;Laboratoires Biove, Francija
|
| Date of authorisation/renewal: |
16-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/257/003 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
Poulvac IB QX
|
-
|
V/I/26/0019
|
Zoetis B.V., Nīderlande
|
QI01AD07
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate for oculonasal suspension
|
| International name (active substance): |
Live attenuated Avian Infectious BronchitisVirus, Strain L1148
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Manufacturing & Research Spain S.L., Spānija
|
| Date of authorisation/renewal: |
10-Apr-2026
|
| Marketing authorisation valid until: |
09-Apr-2031
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 10042026LI (10-Apr-2026)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/26/0019-01 |
|
10 |
Stikla flakons, 5000 deva |
[PDF]
|
|
|
Equip WNV
|
-
|
EU/2/08/086/006
|
Zoetis Belgium S.A., Beļģija
|
QI05AA10
|
horses
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated West Nile V, strain VM-2
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Zoetis Belgium S.A., Beļģija
|
| Date of authorisation/renewal: |
12-Sep-2013
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/086/006 |
|
10 |
Stikla pilnšļirce ar 1 adatu, 1 ml |
-
|
|
|
REXXOLIDE
|
100 mg/ml
|
EU/2/20/263/003
|
Dechra Regulatory B.V., Nīderlande
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tulathromycin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande
|
| Date of authorisation/renewal: |
03-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/263/003 |
100 mg/ml |
1 |
Stikla flakons, 250 ml |
-
|
|